{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T17:24:02Z","timestamp":1792949042444,"version":"4.5.0"},"reference-count":51,"publisher":"American Society of Hematology","issue":"17","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,4,27]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>miR-28 is a regulator of the GC reaction that dampens B-cell receptor signaling and impairs B-cell proliferation and survival. miR-28 has antitumoral activity in BL and DLBCL.<\/jats:p>","DOI":"10.1182\/blood-2016-08-731166","type":"journal-article","created":{"date-parts":[[2017,2,10]],"date-time":"2017-02-10T20:40:16Z","timestamp":1486759216000},"page":"2408-2419","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":45,"title":["miR-28 regulates the germinal center reaction and blocks tumor growth in preclinical models of non-Hodgkin lymphoma"],"prefix":"10.1182","volume":"129","author":[{"given":"Nahikari","family":"Bartolom\u00e9-Izquierdo","sequence":"first","affiliation":[{"name":"B Cell Biology Laboratory and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3785-5868","authenticated-orcid":false,"given":"Virginia G.","family":"de Y\u00e9benes","sequence":"additional","affiliation":[{"name":"B Cell Biology Laboratory and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0622-2993","authenticated-orcid":false,"given":"Angel F.","family":"\u00c1lvarez-Prado","sequence":"additional","affiliation":[{"name":"B Cell Biology Laboratory and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia M.","family":"Mur","sequence":"additional","affiliation":[{"name":"B Cell Biology Laboratory and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9097-6060","authenticated-orcid":false,"given":"Juan A.","family":"Lopez del Olmo","sequence":"additional","affiliation":[{"name":"Cardiovascular Proteomics Laboratory, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1095-0715","authenticated-orcid":false,"given":"Sergio","family":"Roa","sequence":"additional","affiliation":[{"name":"Division of Oncology, Center for Applied Medical Research, University of Navarra, Pamplona, Spain; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1461-5092","authenticated-orcid":false,"given":"Jesus","family":"Vazquez","sequence":"additional","affiliation":[{"name":"Cardiovascular Proteomics Laboratory, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain;"},{"name":"CIBER de Enfermedades Cardiovasculares, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7539-3844","authenticated-orcid":false,"given":"Almudena R.","family":"Ramiro","sequence":"additional","affiliation":[{"name":"B Cell Biology Laboratory and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111903262215400_B1","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1146\/annurev-immunol-020711-075027","article-title":"Pathogenesis of human B cell lymphomas","volume":"30","author":"Shaffer","year":"2012","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"2019111903262215400_B2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/nrclinonc.2013.197","article-title":"Diffuse large B-cell lymphoma-treatment approaches in the molecular era","volume":"11","author":"Roschewski","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"key":"2019111903262215400_B3","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1146\/annurev-immunol-020711-075032","article-title":"Germinal centers","volume":"30","author":"Victora","year":"2012","journal-title":"Annu Rev Immunol"},{"issue":"5","key":"2019111903262215400_B4","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0092-8674(00)00078-7","article-title":"Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme","volume":"102","author":"Muramatsu","year":"2000","journal-title":"Cell"},{"key":"2019111903262215400_B5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.biochem.76.061705.090740","article-title":"Molecular mechanisms of antibody somatic hypermutation","volume":"76","author":"Di Noia","year":"2007","journal-title":"Annu Rev Biochem"},{"issue":"7080","key":"2019111903262215400_B6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature04495","article-title":"Role of genomic instability and p53 in AID-induced c-myc-Igh translocations","volume":"440","author":"Ramiro","year":"2006","journal-title":"Nature"},{"issue":"4","key":"2019111903262215400_B7","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.cell.2004.08.006","article-title":"AID is required for c-myc\/IgH chromosome translocations in vivo","volume":"118","author":"Ramiro","year":"2004","journal-title":"Cell"},{"issue":"6","key":"2019111903262215400_B8","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.cell.2008.09.062","article-title":"AID is required for the chromosomal breaks in c-myc that lead to c-myc\/IgH translocations","volume":"135","author":"Robbiani","year":"2008","journal-title":"Cell"},{"issue":"4","key":"2019111903262215400_B9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrc1589","article-title":"Mechanisms of B-cell lymphoma pathogenesis","volume":"5","author":"K\u00fcppers","year":"2005","journal-title":"Nat Rev Cancer"},{"issue":"5312","key":"2019111903262215400_B10","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1126\/science.276.5312.589","article-title":"Control of inflammation, cytokine expression, and germinal center formation by BCL-6","volume":"276","author":"Dent","year":"1997","journal-title":"Science"},{"issue":"5","key":"2019111903262215400_B11","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ccr.2005.03.037","article-title":"Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice","volume":"7","author":"Cattoretti","year":"2005","journal-title":"Cancer Cell"},{"issue":"7","key":"2019111903262215400_B12","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1182\/blood-2009-05-220814","article-title":"Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-MiR-155 transgenic mice","volume":"114","author":"Costinean","year":"2009","journal-title":"Blood"},{"issue":"2","key":"2019111903262215400_B13","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1182\/blood-2013-12-543611","article-title":"miR-217 is an oncogene that enhances the germinal center reaction","volume":"124","author":"de Y\u00e9benes","year":"2014","journal-title":"Blood"},{"issue":"9","key":"2019111903262215400_B14","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1073\/pnas.0307323101","article-title":"Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers","volume":"101","author":"Calin","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"16","key":"2019111903262215400_B15","doi-asserted-by":"crossref","first-page":"R762","DOI":"10.1016\/j.cub.2014.06.043","article-title":"Aberrant regulation and function of microRNAs in cancer","volume":"24","author":"Adams","year":"2014","journal-title":"Curr Biol"},{"issue":"5","key":"2019111903262215400_B16","doi-asserted-by":"crossref","first-page":"580","DOI":"10.2174\/1566524014666140603095414","article-title":"Role of microRNAs in B cell leukemias and lymphomas","volume":"14","author":"Schmidt","year":"2014","journal-title":"Curr Mol Med"},{"issue":"1","key":"2019111903262215400_B17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/imr.12046","article-title":"Regulation of B-cell development and function by microRNAs","volume":"253","author":"de Y\u00e9benes","year":"2013","journal-title":"Immunol Rev"},{"issue":"30","key":"2019111903262215400_B18","first-page":"1","article-title":"Therapeutic opportunities for targeting microRNAs in cancer","volume":"2","author":"Taylor","year":"2014","journal-title":"Mol Cell Ther"},{"issue":"1","key":"2019111903262215400_B19","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/clpt.2012.192","article-title":"Clinical applications for microRNAs in cancer","volume":"93","author":"Nana-Sinkam","year":"2013","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"2019111903262215400_B20","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1084\/jem.20080579","article-title":"miR-181b negatively regulates activation-induced cytidine deaminase in B cells","volume":"205","author":"de Y\u00e9benes","year":"2008","journal-title":"J Exp Med"},{"issue":"6","key":"2019111903262215400_B21","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.immuni.2010.05.009","article-title":"Regulation of microRNA expression and abundance during lymphopoiesis","volume":"32","author":"Kuchen","year":"2010","journal-title":"Immunity"},{"issue":"5","key":"2019111903262215400_B22","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.immuni.2009.03.017","article-title":"Identification of the human mature B cell miRNome","volume":"30","author":"Basso","year":"2009","journal-title":"Immunity"},{"issue":"9","key":"2019111903262215400_B23","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nmeth1079","article-title":"MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells","volume":"4","author":"Ebert","year":"2007","journal-title":"Nat Methods"},{"issue":"2","key":"2019111903262215400_B24","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1038\/bcj.2012.1","article-title":"MicroRNA signatures in B-cell lymphomas","volume":"2","author":"Di Lisio","year":"2012","journal-title":"Blood Cancer J"},{"issue":"22","key":"2019111903262215400_B25","doi-asserted-by":"crossref","first-page":"8185","DOI":"10.1073\/pnas.1322466111","article-title":"MicroRNA 28 controls cell proliferation and is down-regulated in B-cell lymphomas","volume":"111","author":"Schneider","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"2019111903262215400_B26","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1182\/blood-2014-04-566778","article-title":"Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma","volume":"125","author":"Iqbal","year":"2015","journal-title":"Blood"},{"issue":"3","key":"2019111903262215400_B27","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","article-title":"PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes","volume":"34","author":"Mootha","year":"2003","journal-title":"Nat Genet"},{"key":"2019111903262215400_B28","author":"Garcia-Marqu\u00e9s"},{"issue":"7277","key":"2019111903262215400_B29","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature08638","article-title":"Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma","volume":"463","author":"Davis","year":"2010","journal-title":"Nature"},{"key":"2019111903262215400_B30","author":"Sibley"},{"issue":"8","key":"2019111903262215400_B31","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1084\/jem.192.8.1183","article-title":"Burkitt lymphoma in the mouse","volume":"192","author":"Kovalchuk","year":"2000","journal-title":"J Exp Med"},{"issue":"7209","key":"2019111903262215400_B32","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nature07228","article-title":"Widespread changes in protein synthesis induced by microRNAs","volume":"455","author":"Selbach","year":"2008","journal-title":"Nature"},{"key":"2019111903262215400_B33","doi-asserted-by":"crossref","first-page":"8725","DOI":"10.1038\/ncomms9725","article-title":"miR-17-92 fine-tunes MYC expression and function to ensure optimal B cell lymphoma growth","volume":"6","author":"Mihailovich","year":"2015","journal-title":"Nat Commun"},{"issue":"5569","key":"2019111903262215400_B34","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1126\/science.1069398","article-title":"Genomic instability in mice lacking histone H2AX","volume":"296","author":"Celeste","year":"2002","journal-title":"Science"},{"issue":"2","key":"2019111903262215400_B35","doi-asserted-by":"crossref","first-page":"a014282","DOI":"10.1101\/cshperspect.a014282","article-title":"Oncogenic mechanisms in Burkitt lymphoma","volume":"4","author":"Schmitz","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"8","key":"2019111903262215400_B36","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nri3487","article-title":"New insights into pre-BCR and BCR signalling with relevance to B cell malignancies","volume":"13","author":"Rickert","year":"2013","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"2019111903262215400_B37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1053\/j.seminhematol.2015.01.008","article-title":"B-cell receptor signaling in diffuse large B-cell lymphoma","volume":"52","author":"Young","year":"2015","journal-title":"Semin Hematol"},{"key":"2019111903262215400_B38","author":"Cheah"},{"issue":"3","key":"2019111903262215400_B39","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1172\/JCI11991","article-title":"Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB","volume":"107","author":"Baldwin","year":"2001","journal-title":"J Clin Invest"},{"issue":"31","key":"2019111903262215400_B40","doi-asserted-by":"crossref","first-page":"11365","DOI":"10.1073\/pnas.1411701111","article-title":"Blockade of oncogenic I\u03baB kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitors","volume":"111","author":"Ceribelli","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"18","key":"2019111903262215400_B41","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.4161\/cc.25972","article-title":"Protect and serve: Bcl-2 proteins as guardians and rulers of cancer cell survival","volume":"12","author":"Braun","year":"2013","journal-title":"Cell Cycle"},{"issue":"12","key":"2019111903262215400_B42","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/nm.2059","article-title":"A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas","volume":"15","author":"Cerchietti","year":"2009","journal-title":"Nat Med"},{"issue":"1","key":"2019111903262215400_B43","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1073\/pnas.1008969108","article-title":"Critical role of PI3K signaling for NF-kappaB-dependent survival in a subset of activated B-cell-like diffuse large B-cell lymphoma cells","volume":"108","author":"Kloo","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"2019111903262215400_B44","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccr.2012.06.012","article-title":"Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis","volume":"22","author":"Sander","year":"2012","journal-title":"Cancer Cell"},{"issue":"7418","key":"2019111903262215400_B45","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature11378","article-title":"Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics","volume":"490","author":"Schmitz","year":"2012","journal-title":"Nature"},{"issue":"5","key":"2019111903262215400_B46","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/leu.2014.351","article-title":"MicroRNAs in B-cell lymphomas: how a complex biology gets more complex","volume":"29","author":"Musilova","year":"2015","journal-title":"Leukemia"},{"issue":"1","key":"2019111903262215400_B47","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1600-065X.2012.01105.x","article-title":"Pathogenetic importance and therapeutic implications of NF-\u03baB in lymphoid malignancies","volume":"246","author":"Lim","year":"2012","journal-title":"Immunol Rev"},{"issue":"29","key":"2019111903262215400_B48","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.2174\/0929867311320290002","article-title":"MicroRNAs and cancer therapy - from bystanders to major players","volume":"20","author":"Braicu","year":"2013","journal-title":"Curr Med Chem"},{"issue":"18","key":"2019111903262215400_B49","doi-asserted-by":"crossref","first-page":"7027","DOI":"10.1158\/0008-5472.CAN-10-2010","article-title":"The promise of microRNA replacement therapy","volume":"70","author":"Bader","year":"2010","journal-title":"Cancer Res"},{"issue":"36","key":"2019111903262215400_B50","doi-asserted-by":"crossref","first-page":"13520","DOI":"10.1073\/pnas.0804295105","article-title":"Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways","volume":"105","author":"Lenz","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"2019111903262215400_B51","doi-asserted-by":"crossref","first-page":"491","DOI":"10.4149\/neo_2014_062","article-title":"Diffuse large B-cell lymphoma: the history, current view and new perspectives","volume":"61","author":"Flodr","year":"2014","journal-title":"Neoplasma"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/17\/2408\/1400156\/blood731166.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/17\/2408\/1400156\/blood731166.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T03:27:10Z","timestamp":1574134030000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/129\/17\/2408\/35966\/miR28-regulates-the-germinal-center-reaction-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,27]]},"references-count":51,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2017,4,27]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2016-08-731166","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,27]]}}}